nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—SLC6A2—hypertension	0.325	0.725	CbGaD
Milnacipran—SLC6A2—Guanadrel—hypertension	0.142	0.454	CbGbCtD
Milnacipran—SLC6A4—hypertension	0.124	0.276	CbGaD
Milnacipran—SLC6A2—Guanethidine—hypertension	0.108	0.344	CbGbCtD
Milnacipran—SLC6A2—Clonidine—hypertension	0.0339	0.108	CbGbCtD
Milnacipran—SLC6A4—Verapamil—hypertension	0.0292	0.0932	CbGbCtD
Milnacipran—SLC6A2—locus ceruleus—hypertension	0.00504	0.316	CbGeAlD
Milnacipran—SLC6A2—sympathetic nervous system—hypertension	0.00398	0.25	CbGeAlD
Milnacipran—SLC6A2—autonomic nervous system—hypertension	0.00268	0.168	CbGeAlD
Milnacipran—Levomilnacipran—CYP2J2—hypertension	0.00173	0.407	CrCbGaD
Milnacipran—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A19—hypertension	0.00128	0.0362	CbGpPWpGaD
Milnacipran—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A18—hypertension	0.00128	0.0362	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—SLC6A2—hypertension	0.00108	0.0307	CbGpPWpGaD
Milnacipran—SLC6A2—Amine compound SLC transporters—SLC6A18—hypertension	0.000885	0.0251	CbGpPWpGaD
Milnacipran—SLC6A2—Amine compound SLC transporters—SLC6A19—hypertension	0.000885	0.0251	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—DBH—hypertension	0.000871	0.0247	CbGpPWpGaD
Milnacipran—SLC6A4—Serotonin Transporter Activity—NOS1—hypertension	0.000838	0.0238	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—DBH—hypertension	0.000749	0.0213	CbGpPWpGaD
Milnacipran—SLC6A4—brainstem—hypertension	0.000734	0.046	CbGeAlD
Milnacipran—SLC6A4—Synaptic Vesicle Pathway—ATP1A2—hypertension	0.000706	0.02	CbGpPWpGaD
Milnacipran—Levomilnacipran—SLC6A2—hypertension	0.000668	0.157	CrCbGaD
Milnacipran—Diethylpropion—SLC6A2—hypertension	0.000647	0.152	CrCbGaD
Milnacipran—SLC6A2—brainstem—hypertension	0.000646	0.0405	CbGeAlD
Milnacipran—SLC6A4—Serotonin Transporter Activity—ITGB3—hypertension	0.000618	0.0175	CbGpPWpGaD
Milnacipran—SLC6A2—decidua—hypertension	0.000544	0.0341	CbGeAlD
Milnacipran—SLC6A4—Monoamine Transport—HRH3—hypertension	0.000492	0.014	CbGpPWpGaD
Milnacipran—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—hypertension	0.000465	0.0132	CbGpPWpGaD
Milnacipran—SLC6A2—medulla oblongata—hypertension	0.000451	0.0282	CbGeAlD
Milnacipran—SLC6A2—Monoamine Transport—HRH3—hypertension	0.000423	0.012	CbGpPWpGaD
Milnacipran—SLC6A2—adrenal gland—hypertension	0.000417	0.0261	CbGeAlD
Milnacipran—SLC6A4—endocrine gland—hypertension	0.000411	0.0258	CbGeAlD
Milnacipran—SLC6A4—central nervous system—hypertension	0.00037	0.0232	CbGeAlD
Milnacipran—SLC6A2—endocrine gland—hypertension	0.000362	0.0227	CbGeAlD
Milnacipran—SLC6A4—Monoamine Transport—SLC6A3—hypertension	0.000357	0.0101	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—NOS1—hypertension	0.000357	0.0101	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—TH—hypertension	0.000357	0.0101	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A19—hypertension	0.000346	0.00983	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A18—hypertension	0.000346	0.00983	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—SLC6A4—hypertension	0.000344	0.00976	CbGpPWpGaD
Milnacipran—SLC6A4—Serotonin Transporter Activity—IL1B—hypertension	0.000342	0.0097	CbGpPWpGaD
Milnacipran—Diethylpropion—SLC6A3—hypertension	0.000329	0.0773	CrCbGaD
Milnacipran—SLC6A2—central nervous system—hypertension	0.000326	0.0204	CbGeAlD
Milnacipran—SLC6A2—Amine compound SLC transporters—SLC6A3—hypertension	0.000323	0.00916	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC6A2—hypertension	0.000321	0.00911	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTA5—hypertension	0.000321	0.00911	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—SLC6A3—hypertension	0.000307	0.0087	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—TH—hypertension	0.000307	0.0087	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—NOS1—hypertension	0.000307	0.0087	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTT2—hypertension	0.000304	0.00864	CbGpPWpGaD
Milnacipran—Pethidine—SLC6A2—hypertension	0.000301	0.0707	CrCbGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC6A18—hypertension	0.00029	0.00824	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC6A19—hypertension	0.00029	0.00824	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GSTA5—hypertension	0.000276	0.00783	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—KCNQ1—hypertension	0.000264	0.00749	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—KCNJ8—hypertension	0.000264	0.00749	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—ITGB3—hypertension	0.000263	0.00746	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GSTT2—hypertension	0.000262	0.00743	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTM5—hypertension	0.000259	0.00734	CbGpPWpGaD
Milnacipran—Levomilnacipran—SLC6A4—hypertension	0.000254	0.0597	CrCbGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC6A19—hypertension	0.00025	0.00708	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC6A18—hypertension	0.00025	0.00708	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—ECE1—hypertension	0.000245	0.00696	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—hypertension	0.000242	0.00687	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—AGT—hypertension	0.000233	0.00661	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—hypertension	0.000226	0.00643	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—ITGB3—hypertension	0.000226	0.00642	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GSTM5—hypertension	0.000222	0.00631	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—SLC9A3—hypertension	0.000219	0.00621	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC12A1—hypertension	0.000218	0.00618	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC12A3—hypertension	0.000218	0.00618	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—CYP4A11—hypertension	0.000211	0.00599	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—AHCY—hypertension	0.000207	0.00589	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC5A2—hypertension	0.000203	0.00576	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—AGT—hypertension	0.0002	0.00568	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SOD3—hypertension	0.000196	0.00556	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC2A3—hypertension	0.00019	0.00539	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TPH1—hypertension	0.000186	0.00528	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—CYP4A11—hypertension	0.000181	0.00515	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—SLC9A3—hypertension	0.000179	0.00507	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—hypertension	0.000177	0.00503	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC5A2—hypertension	0.000175	0.00495	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SOD3—hypertension	0.000169	0.00479	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC4A4—hypertension	0.000165	0.00468	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—UTS2R—hypertension	0.000163	0.00463	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC2A3—hypertension	0.000163	0.00463	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HADHA—hypertension	0.000162	0.00459	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—AQP4—hypertension	0.000158	0.00449	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC6A18—hypertension	0.000157	0.00446	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC6A19—hypertension	0.000157	0.00446	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ADORA1—hypertension	0.000157	0.00446	CbGpPWpGaD
Milnacipran—Pethidine—SLC6A3—hypertension	0.000153	0.036	CrCbGaD
Milnacipran—SLC6A4—Circadian rythm related genes—TPH1—hypertension	0.000152	0.00431	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HSPD1—hypertension	0.000149	0.00422	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—IL1B—hypertension	0.000145	0.00413	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ADA—hypertension	0.000145	0.00411	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TGFA—hypertension	0.000142	0.00402	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GPX3—hypertension	0.000142	0.00402	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TACR1—hypertension	0.000141	0.004	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SERPINA1—hypertension	0.00014	0.00396	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ROCK2—hypertension	0.000137	0.00389	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—UTS2—hypertension	0.000129	0.00366	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GCLC—hypertension	0.000128	0.00363	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—hypertension	0.000126	0.00358	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—IL1B—hypertension	0.000125	0.00355	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC9A3—hypertension	0.000125	0.00355	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC12A2—hypertension	0.000125	0.00355	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL13—hypertension	0.000125	0.00354	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—CLCNKB—hypertension	0.000124	0.00352	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SCNN1G—hypertension	0.000124	0.00352	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—WNK4—hypertension	0.000124	0.00352	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—CLCNKA—hypertension	0.000124	0.00352	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—WNK1—hypertension	0.000124	0.00352	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SCNN1B—hypertension	0.000124	0.00352	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—hypertension	0.000123	0.00349	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TGFA—hypertension	0.000122	0.00346	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GPX3—hypertension	0.000122	0.00346	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SERPINA1—hypertension	0.00012	0.00341	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—AHR—hypertension	0.000118	0.00335	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TAC1—hypertension	0.000115	0.00326	CbGpPWpGaD
Milnacipran—Pethidine—SLC6A4—hypertension	0.000114	0.0269	CrCbGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—AQP2—hypertension	0.000111	0.00314	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC12A1—hypertension	0.000111	0.00314	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC12A3—hypertension	0.000111	0.00314	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—FXYD2—hypertension	0.000111	0.00314	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC5A2—hypertension	0.00011	0.00312	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GCLC—hypertension	0.00011	0.00312	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—SST—hypertension	0.00011	0.00311	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1RN—hypertension	0.000109	0.0031	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CST3—hypertension	0.000109	0.00309	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC6A3—hypertension	0.000106	0.003	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—TNF—hypertension	0.000106	0.003	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC2A4—hypertension	0.000103	0.00292	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC2A3—hypertension	0.000103	0.00292	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC6A4—hypertension	0.000102	0.0029	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—ESR2—hypertension	0.000101	0.00287	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TH—hypertension	0.0001	0.00285	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—EGR1—hypertension	9.97e-05	0.00283	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—F7—hypertension	9.78e-05	0.00278	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—EGR1—hypertension	9.46e-05	0.00268	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC8A1—hypertension	9.35e-05	0.00266	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HDAC1—hypertension	9.18e-05	0.00261	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC6A3—hypertension	9.1e-05	0.00258	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—TNF—hypertension	9.07e-05	0.00258	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—GJA1—hypertension	9.01e-05	0.00256	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TGFBR2—hypertension	8.96e-05	0.00254	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—AR—hypertension	8.93e-05	0.00254	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—DRD3—hypertension	8.91e-05	0.00253	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC2A4—hypertension	8.86e-05	0.00251	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—HMOX1—hypertension	8.84e-05	0.00251	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—GHRL—hypertension	8.72e-05	0.00247	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—EGR1—hypertension	8.58e-05	0.00243	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ADIPOQ—hypertension	8.44e-05	0.0024	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—GNB3—hypertension	8.42e-05	0.00239	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—hypertension	8.42e-05	0.00239	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC4A4—hypertension	8.38e-05	0.00238	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP1A1—hypertension	8.38e-05	0.00238	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—TRPC5—hypertension	8.38e-05	0.00238	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP1A2—hypertension	8.38e-05	0.00238	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP2B3—hypertension	8.38e-05	0.00238	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—AVP—hypertension	8.3e-05	0.00236	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTM1—hypertension	8.23e-05	0.00234	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—TH—hypertension	8.2e-05	0.00233	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—DRD2—hypertension	8.06e-05	0.00229	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—HTR7—hypertension	8.06e-05	0.00229	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—CP—hypertension	8.05e-05	0.00229	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC6A19—hypertension	7.99e-05	0.00227	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC6A18—hypertension	7.99e-05	0.00227	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SCNN1A—hypertension	7.99e-05	0.00227	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—AGER—hypertension	7.94e-05	0.00225	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL10—hypertension	7.81e-05	0.00222	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—EGR1—hypertension	7.72e-05	0.00219	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TGFBR2—hypertension	7.7e-05	0.00219	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—NGFR—hypertension	7.68e-05	0.00218	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—HMOX1—hypertension	7.6e-05	0.00216	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—HDAC1—hypertension	7.5e-05	0.00213	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—YWHAZ—hypertension	7.34e-05	0.00208	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—NGF—hypertension	7.26e-05	0.00206	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—NR3C1—hypertension	7.22e-05	0.00205	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—PDGFB—hypertension	7.08e-05	0.00201	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GSTM1—hypertension	7.08e-05	0.00201	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—hypertension	7e-05	0.00199	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR2A—hypertension	6.91e-05	0.00196	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PPARGC1A—hypertension	6.87e-05	0.00195	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—AGER—hypertension	6.83e-05	0.00194	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—AVP—hypertension	6.78e-05	0.00192	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—COX5B—hypertension	6.7e-05	0.0019	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—AVPR2—hypertension	6.7e-05	0.0019	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP1B1—hypertension	6.7e-05	0.0019	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HIF1A—hypertension	6.58e-05	0.00187	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC9A3—hypertension	6.35e-05	0.0018	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC12A2—hypertension	6.35e-05	0.0018	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—PDGFB—hypertension	6.09e-05	0.00173	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PRKCG—hypertension	6.08e-05	0.00173	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ABCC9—hypertension	6.06e-05	0.00172	CbGpPWpGaD
Milnacipran—Pethidine—ALB—hypertension	6.02e-05	0.0141	CrCbGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SGK1—hypertension	5.81e-05	0.00165	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—hypertension	5.74e-05	0.00163	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC5A2—hypertension	5.59e-05	0.00159	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—hypertension	5.58e-05	0.00158	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PPARA—hypertension	5.53e-05	0.00157	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ABCC1—hypertension	5.4e-05	0.00153	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—NEDD4L—hypertension	5.4e-05	0.00153	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—LEP—hypertension	5.25e-05	0.00149	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC2A3—hypertension	5.23e-05	0.00148	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP2B1—hypertension	5.15e-05	0.00146	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP2A3—hypertension	5.08e-05	0.00144	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—AQP1—hypertension	5.08e-05	0.00144	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—NOS2—hypertension	4.89e-05	0.00139	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC8A1—hypertension	4.75e-05	0.00135	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—AVP—hypertension	4.75e-05	0.00135	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—AQP4—hypertension	4.59e-05	0.0013	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PPARG—hypertension	4.57e-05	0.0013	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—TRPC3—hypertension	4.4e-05	0.00125	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CXCL8—hypertension	4.27e-05	0.00121	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—SERPINE1—hypertension	4.12e-05	0.00117	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1B—hypertension	4.1e-05	0.00116	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—CP—hypertension	4.09e-05	0.00116	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—EP300—hypertension	3.66e-05	0.00104	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC9A1—hypertension	3.56e-05	0.00101	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—CETP—hypertension	3.52e-05	0.000999	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—VEGFA—hypertension	3.47e-05	0.000984	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TGFB1—hypertension	3.36e-05	0.000952	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PTEN—hypertension	3.13e-05	0.00089	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—PLAT—hypertension	3.1e-05	0.00088	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—MAPK8—hypertension	3.07e-05	0.00087	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—EP300—hypertension	2.99e-05	0.000848	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—hypertension	2.97e-05	0.000843	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC6A3—hypertension	2.92e-05	0.000828	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TGFB1—hypertension	2.89e-05	0.000819	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—ALB—hypertension	2.88e-05	0.000816	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC2A4—hypertension	2.84e-05	0.000805	CbGpPWpGaD
Milnacipran—Diarrhoea—Valsartan—hypertension	2.78e-05	0.000152	CcSEcCtD
Milnacipran—Asthenia—Clonidine—hypertension	2.78e-05	0.000152	CcSEcCtD
Milnacipran—Vomiting—Verapamil—hypertension	2.78e-05	0.000151	CcSEcCtD
Milnacipran—Urticaria—Irbesartan—hypertension	2.78e-05	0.000151	CcSEcCtD
Milnacipran—Shock—Ramipril—hypertension	2.78e-05	0.000151	CcSEcCtD
Milnacipran—Hypersensitivity—Enalapril—hypertension	2.78e-05	0.000151	CcSEcCtD
Milnacipran—Body temperature increased—Perindopril—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Abdominal pain—Perindopril—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Palpitations—Lisinopril—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Diarrhoea—Olmesartan—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Headache—Eplerenone—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Rash—Nifedipine—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Nervous system disorder—Ramipril—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Dermatitis—Nifedipine—hypertension	2.77e-05	0.000151	CcSEcCtD
Milnacipran—Body temperature increased—Irbesartan—hypertension	2.76e-05	0.000151	CcSEcCtD
Milnacipran—Abdominal pain—Irbesartan—hypertension	2.76e-05	0.000151	CcSEcCtD
Milnacipran—Thrombocytopenia—Ramipril—hypertension	2.76e-05	0.000151	CcSEcCtD
Milnacipran—Loss of consciousness—Lisinopril—hypertension	2.76e-05	0.00015	CcSEcCtD
Milnacipran—Rash—Verapamil—hypertension	2.76e-05	0.00015	CcSEcCtD
Milnacipran—Urticaria—Hydrochlorothiazide—hypertension	2.76e-05	0.00015	CcSEcCtD
Milnacipran—Tachycardia—Ramipril—hypertension	2.75e-05	0.00015	CcSEcCtD
Milnacipran—Dermatitis—Verapamil—hypertension	2.75e-05	0.00015	CcSEcCtD
Milnacipran—Headache—Nifedipine—hypertension	2.75e-05	0.00015	CcSEcCtD
Milnacipran—Pruritus—Clonidine—hypertension	2.74e-05	0.00015	CcSEcCtD
Milnacipran—Abdominal pain—Hydrochlorothiazide—hypertension	2.74e-05	0.000149	CcSEcCtD
Milnacipran—Body temperature increased—Hydrochlorothiazide—hypertension	2.74e-05	0.000149	CcSEcCtD
Milnacipran—Skin disorder—Ramipril—hypertension	2.74e-05	0.000149	CcSEcCtD
Milnacipran—Infection—Timolol—hypertension	2.74e-05	0.000149	CcSEcCtD
Milnacipran—Headache—Verapamil—hypertension	2.74e-05	0.000149	CcSEcCtD
Milnacipran—Hypersensitivity—Telmisartan—hypertension	2.74e-05	0.000149	CcSEcCtD
Milnacipran—Nausea—Diltiazem—hypertension	2.73e-05	0.000149	CcSEcCtD
Milnacipran—Nausea—Indapamide—hypertension	2.73e-05	0.000149	CcSEcCtD
Milnacipran—Hyperhidrosis—Ramipril—hypertension	2.73e-05	0.000149	CcSEcCtD
Milnacipran—Asthenia—Trandolapril—hypertension	2.71e-05	0.000148	CcSEcCtD
Milnacipran—Shock—Timolol—hypertension	2.71e-05	0.000148	CcSEcCtD
Milnacipran—Urticaria—Furosemide—hypertension	2.71e-05	0.000148	CcSEcCtD
Milnacipran—Nervous system disorder—Timolol—hypertension	2.71e-05	0.000147	CcSEcCtD
Milnacipran—Nausea—Carvedilol—hypertension	2.71e-05	0.000147	CcSEcCtD
Milnacipran—Asthenia—Enalapril—hypertension	2.7e-05	0.000147	CcSEcCtD
Milnacipran—Abdominal pain—Furosemide—hypertension	2.7e-05	0.000147	CcSEcCtD
Milnacipran—Body temperature increased—Furosemide—hypertension	2.7e-05	0.000147	CcSEcCtD
Milnacipran—Gastrointestinal pain—Losartan—hypertension	2.69e-05	0.000147	CcSEcCtD
Milnacipran—Dizziness—Valsartan—hypertension	2.69e-05	0.000147	CcSEcCtD
Milnacipran—Anorexia—Ramipril—hypertension	2.69e-05	0.000147	CcSEcCtD
Milnacipran—Urticaria—Betaxolol—hypertension	2.68e-05	0.000146	CcSEcCtD
Milnacipran—Skin disorder—Timolol—hypertension	2.68e-05	0.000146	CcSEcCtD
Milnacipran—Dizziness—Olmesartan—hypertension	2.68e-05	0.000146	CcSEcCtD
Milnacipran—Pruritus—Trandolapril—hypertension	2.68e-05	0.000146	CcSEcCtD
Milnacipran—Nausea—Doxazosin—hypertension	2.68e-05	0.000146	CcSEcCtD
Milnacipran—Chest pain—Lisinopril—hypertension	2.67e-05	0.000145	CcSEcCtD
Milnacipran—Body temperature increased—Betaxolol—hypertension	2.67e-05	0.000145	CcSEcCtD
Milnacipran—Hyperhidrosis—Timolol—hypertension	2.67e-05	0.000145	CcSEcCtD
Milnacipran—Asthenia—Telmisartan—hypertension	2.67e-05	0.000145	CcSEcCtD
Milnacipran—Pruritus—Enalapril—hypertension	2.67e-05	0.000145	CcSEcCtD
Milnacipran—Anxiety—Lisinopril—hypertension	2.66e-05	0.000145	CcSEcCtD
Milnacipran—Diarrhoea—Clonidine—hypertension	2.65e-05	0.000145	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.65e-05	0.000144	CcSEcCtD
Milnacipran—Nausea—Fosinopril—hypertension	2.64e-05	0.000144	CcSEcCtD
Milnacipran—Hypotension—Ramipril—hypertension	2.64e-05	0.000144	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—PLG—hypertension	2.64e-05	0.000748	CbGpPWpGaD
Milnacipran—Anorexia—Timolol—hypertension	2.63e-05	0.000143	CcSEcCtD
Milnacipran—Pruritus—Telmisartan—hypertension	2.63e-05	0.000143	CcSEcCtD
Milnacipran—Nausea—Eplerenone—hypertension	2.63e-05	0.000143	CcSEcCtD
Milnacipran—Urticaria—Losartan—hypertension	2.61e-05	0.000142	CcSEcCtD
Milnacipran—Dry mouth—Lisinopril—hypertension	2.61e-05	0.000142	CcSEcCtD
Milnacipran—Nausea—Nifedipine—hypertension	2.61e-05	0.000142	CcSEcCtD
Milnacipran—Abdominal pain—Losartan—hypertension	2.6e-05	0.000142	CcSEcCtD
Milnacipran—Body temperature increased—Losartan—hypertension	2.6e-05	0.000142	CcSEcCtD
Milnacipran—Nausea—Verapamil—hypertension	2.6e-05	0.000141	CcSEcCtD
Milnacipran—Asthenia—Captopril—hypertension	2.59e-05	0.000141	CcSEcCtD
Milnacipran—Diarrhoea—Trandolapril—hypertension	2.59e-05	0.000141	CcSEcCtD
Milnacipran—Vomiting—Valsartan—hypertension	2.59e-05	0.000141	CcSEcCtD
Milnacipran—Diarrhoea—Enalapril—hypertension	2.58e-05	0.00014	CcSEcCtD
Milnacipran—Hypotension—Timolol—hypertension	2.58e-05	0.00014	CcSEcCtD
Milnacipran—Hypersensitivity—Irbesartan—hypertension	2.58e-05	0.00014	CcSEcCtD
Milnacipran—Vomiting—Olmesartan—hypertension	2.57e-05	0.00014	CcSEcCtD
Milnacipran—Rash—Valsartan—hypertension	2.57e-05	0.00014	CcSEcCtD
Milnacipran—Dizziness—Clonidine—hypertension	2.56e-05	0.00014	CcSEcCtD
Milnacipran—Dermatitis—Valsartan—hypertension	2.56e-05	0.00014	CcSEcCtD
Milnacipran—Pruritus—Captopril—hypertension	2.56e-05	0.000139	CcSEcCtD
Milnacipran—Hypersensitivity—Hydrochlorothiazide—hypertension	2.56e-05	0.000139	CcSEcCtD
Milnacipran—Rash—Olmesartan—hypertension	2.55e-05	0.000139	CcSEcCtD
Milnacipran—Insomnia—Ramipril—hypertension	2.55e-05	0.000139	CcSEcCtD
Milnacipran—Dermatitis—Olmesartan—hypertension	2.55e-05	0.000139	CcSEcCtD
Milnacipran—Headache—Valsartan—hypertension	2.55e-05	0.000139	CcSEcCtD
Milnacipran—Diarrhoea—Telmisartan—hypertension	2.54e-05	0.000139	CcSEcCtD
Milnacipran—Infection—Lisinopril—hypertension	2.54e-05	0.000139	CcSEcCtD
Milnacipran—Headache—Olmesartan—hypertension	2.54e-05	0.000138	CcSEcCtD
Milnacipran—Paraesthesia—Ramipril—hypertension	2.53e-05	0.000138	CcSEcCtD
Milnacipran—Shock—Lisinopril—hypertension	2.52e-05	0.000137	CcSEcCtD
Milnacipran—Asthenia—Perindopril—hypertension	2.52e-05	0.000137	CcSEcCtD
Milnacipran—Dyspnoea—Ramipril—hypertension	2.52e-05	0.000137	CcSEcCtD
Milnacipran—Hypersensitivity—Furosemide—hypertension	2.51e-05	0.000137	CcSEcCtD
Milnacipran—Asthenia—Irbesartan—hypertension	2.51e-05	0.000137	CcSEcCtD
Milnacipran—Somnolence—Ramipril—hypertension	2.51e-05	0.000137	CcSEcCtD
Milnacipran—Thrombocytopenia—Lisinopril—hypertension	2.51e-05	0.000137	CcSEcCtD
Milnacipran—Dizziness—Trandolapril—hypertension	2.5e-05	0.000136	CcSEcCtD
Milnacipran—Tachycardia—Lisinopril—hypertension	2.5e-05	0.000136	CcSEcCtD
Milnacipran—Insomnia—Timolol—hypertension	2.5e-05	0.000136	CcSEcCtD
Milnacipran—Dizziness—Enalapril—hypertension	2.49e-05	0.000136	CcSEcCtD
Milnacipran—Asthenia—Hydrochlorothiazide—hypertension	2.49e-05	0.000136	CcSEcCtD
Milnacipran—Hypersensitivity—Betaxolol—hypertension	2.49e-05	0.000136	CcSEcCtD
Milnacipran—Skin disorder—Lisinopril—hypertension	2.49e-05	0.000135	CcSEcCtD
Milnacipran—Dyspepsia—Ramipril—hypertension	2.48e-05	0.000135	CcSEcCtD
Milnacipran—Pruritus—Perindopril—hypertension	2.48e-05	0.000135	CcSEcCtD
Milnacipran—Paraesthesia—Timolol—hypertension	2.48e-05	0.000135	CcSEcCtD
Milnacipran—Pruritus—Irbesartan—hypertension	2.47e-05	0.000135	CcSEcCtD
Milnacipran—Hyperhidrosis—Lisinopril—hypertension	2.47e-05	0.000135	CcSEcCtD
Milnacipran—Diarrhoea—Captopril—hypertension	2.47e-05	0.000135	CcSEcCtD
Milnacipran—Vomiting—Clonidine—hypertension	2.47e-05	0.000134	CcSEcCtD
Milnacipran—Dyspnoea—Timolol—hypertension	2.46e-05	0.000134	CcSEcCtD
Milnacipran—Dizziness—Telmisartan—hypertension	2.46e-05	0.000134	CcSEcCtD
Milnacipran—Pruritus—Hydrochlorothiazide—hypertension	2.45e-05	0.000134	CcSEcCtD
Milnacipran—Decreased appetite—Ramipril—hypertension	2.45e-05	0.000134	CcSEcCtD
Milnacipran—Somnolence—Timolol—hypertension	2.45e-05	0.000134	CcSEcCtD
Milnacipran—Asthenia—Furosemide—hypertension	2.45e-05	0.000133	CcSEcCtD
Milnacipran—Rash—Clonidine—hypertension	2.45e-05	0.000133	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—GNB3—hypertension	2.44e-05	0.000694	CbGpPWpGaD
Milnacipran—Dermatitis—Clonidine—hypertension	2.44e-05	0.000133	CcSEcCtD
Milnacipran—Anorexia—Lisinopril—hypertension	2.44e-05	0.000133	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Ramipril—hypertension	2.44e-05	0.000133	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—HMOX1—hypertension	2.43e-05	0.000691	CbGpPWpGaD
Milnacipran—Fatigue—Ramipril—hypertension	2.43e-05	0.000133	CcSEcCtD
Milnacipran—Headache—Clonidine—hypertension	2.43e-05	0.000132	CcSEcCtD
Milnacipran—Dyspepsia—Timolol—hypertension	2.43e-05	0.000132	CcSEcCtD
Milnacipran—Hypersensitivity—Losartan—hypertension	2.42e-05	0.000132	CcSEcCtD
Milnacipran—Asthenia—Betaxolol—hypertension	2.42e-05	0.000132	CcSEcCtD
Milnacipran—Nausea—Valsartan—hypertension	2.42e-05	0.000132	CcSEcCtD
Milnacipran—Pruritus—Furosemide—hypertension	2.41e-05	0.000132	CcSEcCtD
Milnacipran—Constipation—Ramipril—hypertension	2.41e-05	0.000132	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—AVP—hypertension	2.41e-05	0.000684	CbGpPWpGaD
Milnacipran—Nausea—Olmesartan—hypertension	2.41e-05	0.000131	CcSEcCtD
Milnacipran—Vomiting—Trandolapril—hypertension	2.41e-05	0.000131	CcSEcCtD
Milnacipran—Diarrhoea—Perindopril—hypertension	2.4e-05	0.000131	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—hypertension	2.4e-05	0.000681	CbGpPWpGaD
Milnacipran—Decreased appetite—Timolol—hypertension	2.4e-05	0.000131	CcSEcCtD
Milnacipran—Vomiting—Enalapril—hypertension	2.4e-05	0.000131	CcSEcCtD
Milnacipran—Diarrhoea—Irbesartan—hypertension	2.39e-05	0.00013	CcSEcCtD
Milnacipran—Hypotension—Lisinopril—hypertension	2.39e-05	0.00013	CcSEcCtD
Milnacipran—Dizziness—Captopril—hypertension	2.39e-05	0.00013	CcSEcCtD
Milnacipran—Pruritus—Betaxolol—hypertension	2.39e-05	0.00013	CcSEcCtD
Milnacipran—Rash—Trandolapril—hypertension	2.39e-05	0.00013	CcSEcCtD
Milnacipran—Dermatitis—Trandolapril—hypertension	2.38e-05	0.00013	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Timolol—hypertension	2.38e-05	0.00013	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—GNAS—hypertension	2.38e-05	0.000676	CbGpPWpGaD
Milnacipran—Fatigue—Timolol—hypertension	2.38e-05	0.00013	CcSEcCtD
Milnacipran—Rash—Enalapril—hypertension	2.38e-05	0.000129	CcSEcCtD
Milnacipran—Dermatitis—Enalapril—hypertension	2.37e-05	0.000129	CcSEcCtD
Milnacipran—Diarrhoea—Hydrochlorothiazide—hypertension	2.37e-05	0.000129	CcSEcCtD
Milnacipran—Headache—Trandolapril—hypertension	2.37e-05	0.000129	CcSEcCtD
Milnacipran—Vomiting—Telmisartan—hypertension	2.36e-05	0.000129	CcSEcCtD
Milnacipran—Asthenia—Losartan—hypertension	2.36e-05	0.000129	CcSEcCtD
Milnacipran—Headache—Enalapril—hypertension	2.36e-05	0.000129	CcSEcCtD
Milnacipran—Rash—Telmisartan—hypertension	2.34e-05	0.000128	CcSEcCtD
Milnacipran—Dermatitis—Telmisartan—hypertension	2.34e-05	0.000128	CcSEcCtD
Milnacipran—Diarrhoea—Furosemide—hypertension	2.33e-05	0.000127	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—APOB—hypertension	2.33e-05	0.000662	CbGpPWpGaD
Milnacipran—Pruritus—Losartan—hypertension	2.33e-05	0.000127	CcSEcCtD
Milnacipran—Headache—Telmisartan—hypertension	2.33e-05	0.000127	CcSEcCtD
Milnacipran—Dizziness—Perindopril—hypertension	2.32e-05	0.000126	CcSEcCtD
Milnacipran—Insomnia—Lisinopril—hypertension	2.31e-05	0.000126	CcSEcCtD
Milnacipran—Dizziness—Irbesartan—hypertension	2.31e-05	0.000126	CcSEcCtD
Milnacipran—Diarrhoea—Betaxolol—hypertension	2.31e-05	0.000126	CcSEcCtD
Milnacipran—Gastrointestinal pain—Ramipril—hypertension	2.31e-05	0.000126	CcSEcCtD
Milnacipran—Nausea—Clonidine—hypertension	2.3e-05	0.000126	CcSEcCtD
Milnacipran—Paraesthesia—Lisinopril—hypertension	2.3e-05	0.000125	CcSEcCtD
Milnacipran—Vomiting—Captopril—hypertension	2.3e-05	0.000125	CcSEcCtD
Milnacipran—Dizziness—Hydrochlorothiazide—hypertension	2.29e-05	0.000125	CcSEcCtD
Milnacipran—Dyspnoea—Lisinopril—hypertension	2.28e-05	0.000124	CcSEcCtD
Milnacipran—Rash—Captopril—hypertension	2.28e-05	0.000124	CcSEcCtD
Milnacipran—Dermatitis—Captopril—hypertension	2.28e-05	0.000124	CcSEcCtD
Milnacipran—Somnolence—Lisinopril—hypertension	2.28e-05	0.000124	CcSEcCtD
Milnacipran—Headache—Captopril—hypertension	2.26e-05	0.000123	CcSEcCtD
Milnacipran—Gastrointestinal pain—Timolol—hypertension	2.26e-05	0.000123	CcSEcCtD
Milnacipran—Dizziness—Furosemide—hypertension	2.26e-05	0.000123	CcSEcCtD
Milnacipran—Dyspepsia—Lisinopril—hypertension	2.25e-05	0.000123	CcSEcCtD
Milnacipran—Diarrhoea—Losartan—hypertension	2.25e-05	0.000123	CcSEcCtD
Milnacipran—Nausea—Trandolapril—hypertension	2.25e-05	0.000122	CcSEcCtD
Milnacipran—Urticaria—Ramipril—hypertension	2.24e-05	0.000122	CcSEcCtD
Milnacipran—Nausea—Enalapril—hypertension	2.24e-05	0.000122	CcSEcCtD
Milnacipran—Dizziness—Betaxolol—hypertension	2.23e-05	0.000122	CcSEcCtD
Milnacipran—Vomiting—Perindopril—hypertension	2.23e-05	0.000122	CcSEcCtD
Milnacipran—Abdominal pain—Ramipril—hypertension	2.23e-05	0.000122	CcSEcCtD
Milnacipran—Body temperature increased—Ramipril—hypertension	2.23e-05	0.000122	CcSEcCtD
Milnacipran—Decreased appetite—Lisinopril—hypertension	2.22e-05	0.000121	CcSEcCtD
Milnacipran—Vomiting—Irbesartan—hypertension	2.22e-05	0.000121	CcSEcCtD
Milnacipran—Rash—Perindopril—hypertension	2.21e-05	0.000121	CcSEcCtD
Milnacipran—Dermatitis—Perindopril—hypertension	2.21e-05	0.00012	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Lisinopril—hypertension	2.21e-05	0.00012	CcSEcCtD
Milnacipran—Nausea—Telmisartan—hypertension	2.21e-05	0.00012	CcSEcCtD
Milnacipran—Fatigue—Lisinopril—hypertension	2.21e-05	0.00012	CcSEcCtD
Milnacipran—Vomiting—Hydrochlorothiazide—hypertension	2.21e-05	0.00012	CcSEcCtD
Milnacipran—Rash—Irbesartan—hypertension	2.2e-05	0.00012	CcSEcCtD
Milnacipran—Dermatitis—Irbesartan—hypertension	2.2e-05	0.00012	CcSEcCtD
Milnacipran—Headache—Perindopril—hypertension	2.2e-05	0.00012	CcSEcCtD
Milnacipran—Urticaria—Timolol—hypertension	2.19e-05	0.000119	CcSEcCtD
Milnacipran—Headache—Irbesartan—hypertension	2.19e-05	0.000119	CcSEcCtD
Milnacipran—Constipation—Lisinopril—hypertension	2.19e-05	0.000119	CcSEcCtD
Milnacipran—Rash—Hydrochlorothiazide—hypertension	2.19e-05	0.000119	CcSEcCtD
Milnacipran—Dermatitis—Hydrochlorothiazide—hypertension	2.18e-05	0.000119	CcSEcCtD
Milnacipran—Abdominal pain—Timolol—hypertension	2.18e-05	0.000119	CcSEcCtD
Milnacipran—Body temperature increased—Timolol—hypertension	2.18e-05	0.000119	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ADCY5—hypertension	2.18e-05	0.000618	CbGpPWpGaD
Milnacipran—Dizziness—Losartan—hypertension	2.18e-05	0.000119	CcSEcCtD
Milnacipran—Headache—Hydrochlorothiazide—hypertension	2.17e-05	0.000118	CcSEcCtD
Milnacipran—Vomiting—Furosemide—hypertension	2.17e-05	0.000118	CcSEcCtD
Milnacipran—Rash—Furosemide—hypertension	2.15e-05	0.000117	CcSEcCtD
Milnacipran—Dermatitis—Furosemide—hypertension	2.15e-05	0.000117	CcSEcCtD
Milnacipran—Vomiting—Betaxolol—hypertension	2.15e-05	0.000117	CcSEcCtD
Milnacipran—Nausea—Captopril—hypertension	2.15e-05	0.000117	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—TP53—hypertension	2.14e-05	0.000607	CbGpPWpGaD
Milnacipran—Headache—Furosemide—hypertension	2.14e-05	0.000116	CcSEcCtD
Milnacipran—Rash—Betaxolol—hypertension	2.13e-05	0.000116	CcSEcCtD
Milnacipran—Dermatitis—Betaxolol—hypertension	2.13e-05	0.000116	CcSEcCtD
Milnacipran—Headache—Betaxolol—hypertension	2.12e-05	0.000115	CcSEcCtD
Milnacipran—Gastrointestinal pain—Lisinopril—hypertension	2.09e-05	0.000114	CcSEcCtD
Milnacipran—Vomiting—Losartan—hypertension	2.09e-05	0.000114	CcSEcCtD
Milnacipran—Nausea—Perindopril—hypertension	2.08e-05	0.000114	CcSEcCtD
Milnacipran—Hypersensitivity—Ramipril—hypertension	2.08e-05	0.000113	CcSEcCtD
Milnacipran—Nausea—Irbesartan—hypertension	2.08e-05	0.000113	CcSEcCtD
Milnacipran—Rash—Losartan—hypertension	2.07e-05	0.000113	CcSEcCtD
Milnacipran—Dermatitis—Losartan—hypertension	2.07e-05	0.000113	CcSEcCtD
Milnacipran—Headache—Losartan—hypertension	2.06e-05	0.000112	CcSEcCtD
Milnacipran—Nausea—Hydrochlorothiazide—hypertension	2.06e-05	0.000112	CcSEcCtD
Milnacipran—Urticaria—Lisinopril—hypertension	2.03e-05	0.000111	CcSEcCtD
Milnacipran—Hypersensitivity—Timolol—hypertension	2.03e-05	0.000111	CcSEcCtD
Milnacipran—Nausea—Furosemide—hypertension	2.03e-05	0.00011	CcSEcCtD
Milnacipran—Asthenia—Ramipril—hypertension	2.02e-05	0.00011	CcSEcCtD
Milnacipran—Abdominal pain—Lisinopril—hypertension	2.02e-05	0.00011	CcSEcCtD
Milnacipran—Body temperature increased—Lisinopril—hypertension	2.02e-05	0.00011	CcSEcCtD
Milnacipran—Nausea—Betaxolol—hypertension	2.01e-05	0.000109	CcSEcCtD
Milnacipran—Pruritus—Ramipril—hypertension	2e-05	0.000109	CcSEcCtD
Milnacipran—Asthenia—Timolol—hypertension	1.98e-05	0.000108	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—PPARA—hypertension	1.97e-05	0.000558	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—IL6—hypertension	1.96e-05	0.000556	CbGpPWpGaD
Milnacipran—Nausea—Losartan—hypertension	1.95e-05	0.000107	CcSEcCtD
Milnacipran—Pruritus—Timolol—hypertension	1.95e-05	0.000106	CcSEcCtD
Milnacipran—Diarrhoea—Ramipril—hypertension	1.93e-05	0.000105	CcSEcCtD
Milnacipran—Diarrhoea—Timolol—hypertension	1.89e-05	0.000103	CcSEcCtD
Milnacipran—Hypersensitivity—Lisinopril—hypertension	1.89e-05	0.000103	CcSEcCtD
Milnacipran—Dizziness—Ramipril—hypertension	1.87e-05	0.000102	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—APOA1—hypertension	1.84e-05	0.000523	CbGpPWpGaD
Milnacipran—Asthenia—Lisinopril—hypertension	1.84e-05	0.0001	CcSEcCtD
Milnacipran—Dizziness—Timolol—hypertension	1.82e-05	9.94e-05	CcSEcCtD
Milnacipran—Pruritus—Lisinopril—hypertension	1.81e-05	9.87e-05	CcSEcCtD
Milnacipran—Vomiting—Ramipril—hypertension	1.79e-05	9.78e-05	CcSEcCtD
Milnacipran—Rash—Ramipril—hypertension	1.78e-05	9.7e-05	CcSEcCtD
Milnacipran—Dermatitis—Ramipril—hypertension	1.78e-05	9.69e-05	CcSEcCtD
Milnacipran—Headache—Ramipril—hypertension	1.77e-05	9.63e-05	CcSEcCtD
Milnacipran—Vomiting—Timolol—hypertension	1.75e-05	9.56e-05	CcSEcCtD
Milnacipran—Diarrhoea—Lisinopril—hypertension	1.75e-05	9.54e-05	CcSEcCtD
Milnacipran—Rash—Timolol—hypertension	1.74e-05	9.48e-05	CcSEcCtD
Milnacipran—Dermatitis—Timolol—hypertension	1.74e-05	9.47e-05	CcSEcCtD
Milnacipran—Headache—Timolol—hypertension	1.73e-05	9.42e-05	CcSEcCtD
Milnacipran—Dizziness—Lisinopril—hypertension	1.69e-05	9.22e-05	CcSEcCtD
Milnacipran—Nausea—Ramipril—hypertension	1.68e-05	9.14e-05	CcSEcCtD
Milnacipran—Nausea—Timolol—hypertension	1.64e-05	8.93e-05	CcSEcCtD
Milnacipran—Vomiting—Lisinopril—hypertension	1.63e-05	8.87e-05	CcSEcCtD
Milnacipran—Rash—Lisinopril—hypertension	1.61e-05	8.79e-05	CcSEcCtD
Milnacipran—Dermatitis—Lisinopril—hypertension	1.61e-05	8.79e-05	CcSEcCtD
Milnacipran—Headache—Lisinopril—hypertension	1.6e-05	8.74e-05	CcSEcCtD
Milnacipran—Nausea—Lisinopril—hypertension	1.52e-05	8.28e-05	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—hypertension	1.46e-05	0.000415	CbGpPWpGaD
